Literature DB >> 1804653

Antipyrine kinetics in undernourished diabetics.

J C Shobha1, T C Raghuram, A D Kumar, K Krishnaswamy.   

Abstract

In developing countries diabetics frequently suffer from varying grades of malnutrition. The combined effect of malnutrition and non-insulin dependent diabetes (NIDDM) on the drug metabolising enzyme system has been evaluated using antipyrine as a protodrug. All the patients were under treatment and their plasma glucose values were within normal limits. The AUC of antipyrine was similar in all the groups. Although none of the kinetic parameters was altered in normal diabetics, the clearance of antipyrine was decreased and its half life was prolonged, with an increase in volume of distribution, in undernourished diabetics compared to undernourished controls. The results indicate that diabetes per se may not influence antipyrine kinetics when the blood glucose is well under control, but in the presence of undernutrition, it significantly alters the disposition of the drug.

Entities:  

Mesh:

Substances:

Year:  1991        PMID: 1804653     DOI: 10.1007/BF00314968

Source DB:  PubMed          Journal:  Eur J Clin Pharmacol        ISSN: 0031-6970            Impact factor:   2.953


  18 in total

1.  The antipyrine test in clinical pharmacology: conceptions and misconceptions.

Authors:  E S Vesell
Journal:  Clin Pharmacol Ther       Date:  1979-09       Impact factor: 6.875

2.  Diabetes alters drug metabolism--in vivo studies in a streptozotozin-diabetic rat model.

Authors:  T Zysset; L Sommer
Journal:  Experientia       Date:  1986-05-15

Review 3.  Drug metabolism and pharmacokinetics in malutrition.

Authors:  K Krishnaswamy
Journal:  Clin Pharmacokinet       Date:  1978 May-Jun       Impact factor: 6.447

4.  Further observations on relationships between antipyrine half-life, clearance and volume of distribution: an appraisal of alternative kinetic parameters used to assess the elimination of antipyrine.

Authors:  L G Sultatos; B H Dvorchik; E S Vesell; D G Shand; R A Branch
Journal:  Clin Pharmacokinet       Date:  1980 May-Jun       Impact factor: 6.447

5.  Influence of diabetes mellitus on drug metabolism in man.

Authors:  H Daintith; I H Stevenson; K O'Malley
Journal:  Int J Clin Pharmacol Biopharm       Date:  1976-01

6.  Effect of diabetes on rat liver cytochrome P-450. Evidence for a unique diabetes-dependent rat liver cytochrome P-450.

Authors:  M R Past; D E Cook
Journal:  Biochem Pharmacol       Date:  1982-10-15       Impact factor: 5.858

Review 7.  Influences of diet and nutrition on clinical pharmacokinetics.

Authors:  K E Anderson
Journal:  Clin Pharmacokinet       Date:  1988-06       Impact factor: 6.447

8.  The evaluation of the drug-metabolizing capacity in patients with diabetes mellitus.

Authors:  P I Salmela; E A Sotaniemi; R O Pelkonen
Journal:  Diabetes       Date:  1980-10       Impact factor: 9.461

9.  Drug metabolism in diabetic subjects with fatty livers.

Authors:  H I Pirttiaho; P I Salmela; E A Sotaniemi; R O Pelkonen; U Pitkänen; P V Luoma
Journal:  Br J Clin Pharmacol       Date:  1984-12       Impact factor: 4.335

10.  Microsomal enzymes in malnutrition as determined by plasma half life of antipyrine.

Authors:  K Krishnaswamy; A N Naidu
Journal:  Br Med J       Date:  1977-02-26
View more
  2 in total

1.  Prediction of drug disposition in diabetic patients by means of a physiologically based pharmacokinetic model.

Authors:  Jia Li; Hai-Fang Guo; Can Liu; Zeyu Zhong; Li Liu; Xiao-Dong Liu
Journal:  Clin Pharmacokinet       Date:  2015-02       Impact factor: 6.447

Review 2.  Scaling basic toxicokinetic parameters from rat to man.

Authors:  K Bachmann; D Pardoe; D White
Journal:  Environ Health Perspect       Date:  1996-04       Impact factor: 9.031

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.